References
- Al-Maaieh A, Flanagan DR. Salt and cosolvent effects on ionic drug loading into microspheres using an O/W method. Journal of Controlled Release 2001; 70: 169–181
- Bodmeier R, Chen H, Tyle P, Jarosz P. Pseudoephedrine HCl microspheres formulated into an oral suspension dosage form. Journal of Controlled Release 1991; 15: 65–77
- Bodmer D, Kissel T, Traechslin E. Factors influencing the release of peptides and proteins from biodegaradble parenteral depot systems. Journal of Controlled Release 1992; 21: 129–138
- Eroglu H, Kas HS, Oner L, Tuerkoglu OF, Akalan N, sargon MF, Oezer N. The in-vitro and in-vivo characterization of PLGA : L-PLA microspheres containing dexamethasone sodium phosphate. Journal of Microencapsulation 2001; 18: 603–612
- Freytag T, Dashevsky A, Tillman L, Hardee GE, Bodmeier R. Improvement of the encapsulation efficiency of oligonucleotide-containing biodegradable microspheres. Journal of Controlled Release 2000; 69: 197–207
- Herrmann J, Bodmeier R. The effect of particle microstructure on the somatostatin release from poly(lactide) microspheres prepared by a W/O/W solvent evaporation method. Journal of Controlled Release 1995; 36: 63–71
- Herrmann J, Bodmeier R. Biodegradable, somatostatin acetate containing microspheres prepared by various aqueous and non-aqueous solvent evaporation methods. European Journal of Pharmaceutics and Biopharmaceutics 1998; 45: 75–82
- Huang X, Brazel CS. On the important and mechanisms of burst release in matrix-controlled drug delivery systems. Journal of Controlled Release 2001; 73: 121–136
- Jalil R, Nixon JR. Microencapsulation using poly(dl-lactic acid) III: Effect of polymer molecular weight on the release kinetics. Journal of Microencapsulation 1990; 7: 357–374
- Jeyanthi R, Thanoo BC, Metha RC, DeLuca PP. Effect of solvent removal technique on the matrix characteristics of polylactide/glycolide microspheres for peptide delivery. Journal of Controlled Release 1996; 38: 235–244
- Jiang G, Thanoo BC, DeLuca PP. Effect of osmotic pressure in the solvent extraction phase on BSA release profile from PLGA microspheres. Pharmaceutical Development and Technology 2002; 7: 391–399
- Luan X, Bodmeier R. Influence of the poly(lactide-co-glycolide) type on the leuprolide release from in situ forming microparticle systems. Journal of Controlled Release 2006; 110: 266–272
- O’Donnell PB, McGinity JW. Preparation of microspheres by the solvent evaporation technique. Advanced Drug Delivery Reviews 1997; 28: 25–42
- Pistel KF, Kissel T. Effects of salt addition on the microencapsulation of proteins using W/O/W double emulsion technique. Journal of Microencapsulation 2000; 17: 467–483
- Ravivarapu HB, Burton K, DeLuca PP. Polymer and microsphere blending to alter the release of a peptide from PLGA microspheres. European Journal of Pharmaceutical Science 2000; 50: 263–270
- Takada S, Yamakata Y, Misaki M, Taira K, Kurokawa T. Sustained release of human growth hormone from microcapsules prepared by solvent evaporation technique. Journal of Biomedical Materials Research 2003; 88: 229–242
- Woo BH, Na K-H, Dani BA, Jiang G, Thanoo BC, DeLuca PP. In vitro characterization and in vivo testrosterone suppression of 6-month release poly(D,L-lactide) leuprolide microspheres. Pharmaceutical Research 2002; 19: 546–550